The American Academy of Dermatology’s 2022 annual meeting provided opportunities for attendees to learn about the latest advancements in clinical and cosmetic dermatology, including new and emerging treatments for common skin conditions and new tools that dermatologists can use to better diagnose and follow patients with skin diseases.
Click on the image above to view highlights from our team of analysts.
The American Academy of Dermatology’s 2022 annual meeting provided opportunities for attendees to learn about the latest advancements in clinical and cosmetic dermatology, including new and emerging treatments for common skin conditions and new tools that dermatologists can use to better diagnose and follow patients with skin diseases.
Click on the image above to view highlights from our team of analysts.
The American Academy of Dermatology’s 2022 annual meeting provided opportunities for attendees to learn about the latest advancements in clinical and cosmetic dermatology, including new and emerging treatments for common skin conditions and new tools that dermatologists can use to better diagnose and follow patients with skin diseases.
Click on the image above to view highlights from our team of analysts.
The American Academy of Dermatology’s 2022 annual meeting provided opportunities for attendees to learn about the latest advancements in clinical and cosmetic dermatology, including new and emerging treatments for common skin conditions and new tools that dermatologists can use to better diagnose and follow patients with skin diseases.
Click on the image above to view highlights from our team of analysts.
Pinus koraiensis needle or cone extracts alleviate atopic dermatitis symptoms by regulating immunity and suppressing inflammation in HaCaT cells and Nc/Nga mice
Source : https://onlinelibrary.wiley.com/doi/abs/10.1111/jfbc.14135
Pinus koraiensis needles (PKN) and cones (PKC) have been shown to protect against inflammation and pathogenic bacteria.
In the histological analysis of the dorsal skin, the administration of both extracts significantly decreased mast cell numbers, immune cell infiltration, gaps between the epidermis and dermis, and abnormal cell and nucleus shapes. In conclusion, both PKCX and PKNX treatment alleviated the DNCB-induced clinical symptoms of AD by alleviating...